$7.08 0.24 (+3.51%)
2/10/2012 4:01 PM

Cambrex Corp (NYSE:CBM)

CAPS Rating: 3 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Featured Broker Partners


Advertisement